Upregulation of TLRs and IL-6 as a marker in human colorectal cancer

International Journal of Molecular Sciences

Volumn 16, Issue 1, 2014, Pages 159-177

  Lu, Chien Chang ^a   Kuo, Hsing Chun ^b   Wang, Feng Sheng ^a   Jou, Ming Huey ^a   Lee, Ko Chao ^a   Chuang, Jiin Haur ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Colorectal cancer; Immunohistochemical stain; Real time PCR; Toll like receptors; Western blotting

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 8; IL6 PROTEIN, HUMAN; MESSENGER RNA; TUMOR MARKER;

AGED; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INNATE IMMUNITY; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; CASE CONTROL STUDY; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RNA, MESSENGER; TOLL-LIKE RECEPTORS; UP-REGULATION;

EID: 84919829823     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16010159     Document Type: Article

References (40)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Thun, M.J. Cancer statistics, 2009. CA Cancer J. Clin. 2009, 59, 225-249.
2. Sellon, R.K.; Tonkonogy, S.; Schultz, M.; Dieleman, L.A.; Grenther, W.; Balish, E.; Rennick, D.M.; Sartor, R.B. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 1998, 66, 5224-5231.
3. Kado, S.; Uchida, K.; Funabashi, H.; Iwata, S.; Nagata, Y.; Ando, M.; Onoue, M.; Matsuoka, Y.; Ohwaki, M.; Morotomi, M. Intestinal microflora are necessary for development of spontaneous adenocarcinoma of the large intestine in T-cell receptor beta chain and p53 double knockout mice. Cancer Res. 2001, 61, 2395-2398.
4. Fukata, M.; Hernandez, Y.; Conduah, D.; Cohen, J.; Chen, A.; Breglio, K.; Goo, T.; Hsu, D.; Xu, R.; Abreu, M.T. Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors. Inflamm. Bowel Dis. 2009, 15, 997-1006.
5. Medzhitov, R.; Preston-Hurlburt, P.; Janeway, C.A., Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997, 388, 394-397.
6. Mitcham, J.L.; Parnet, P.; Bonnert, T.P.; Garka, K.E.; Gerhart, M.J.; Slack, J.L.; Gayle, M.A.; Dower, S.K.; Sims, J.E. T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J. Biol. Chem. 1996, 271, 5777-5783.
7. Muzio, M.; Bosisio, D.; Polentarutti, N.; D’amico, G.; Stoppacciaro, A.; Mancinelli, R.; van’t Veer, C.; Penton-Rol, G.; Ruco, L.P.; Allavena, P., et al. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: Selective expression of TLR3 in dendritic cells. J. Immunol. 2000, 164, 5998-6004.
8. Hoshino, K.; Takeuchi, O.; Kawai, T.; Sanjo, H.; Ogawa, T.; Takeda, Y.; Takeda, K.; Akira, S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the Lps gene product. J. Immunol. 1999, 162, 3749-3752.
9. Kobayashi, M.; Saitoh, S.; Tanimura, N.; Takahashi, K.; Kawasaki, K.; Nishijima, M.; Fujimoto, Y.; Fukase, K.; Akashi-Takamura, S.; Miyake, K. Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J. Immunol. 2006, 176, 6211-6218.
10. Akira, S. Toll-like receptor signaling. J. Biol. Chem. 2003, 278, 38105-38108.
11. Schön, M.P.; Schön, M. TLR7 and TLR8 as targets in cancer therapy. Oncogene 2008, 27, 190-199.
12. Heil, F.; Ahmad-Nejad, P.; Hemmi, H.; Hochrein, H.; Ampenberger, F.; Gellert, T.; Dietrich, H.; Lipford, G.; Takeda, K.; Akira, S., et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur. J. Immunol. 2003, 33, 2987-2997.
13. Raeburn, C.D.; Calkins, C.M.; Zimmerman, M.A.; Arya, J.; Barsness, K.A.; Harken, A.H. Toll-like receptors and surgical disease. Surgery 2002, 131, 477-483.
14. Okamoto, M.; Sato, M. Toll-like receptor signaling in anti-cancer immunity. J. Med. Investig. 2003, 50, 9-24.
15. Salaun, B.; Coste, I.; Rissoan, M.C.; Lebecque, S.J.; Renno, T. TLR3 can directly trigger apoptosis in human cancer cells. J. Immunol. 2006, 176, 4894-4901.
16. Fukata, M.; Chen, A.; Vamadevan, A.S.; Cohen, J.; Breglio, K.; Krishnareddy, S.; Hsu, D.; Xu, R.; Harpaz, N.; Dannenberg, A.J., et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007, 133, 1869-1881.
17. Simiantonaki, N.; Kurzik-Dumke, U.; Karyofylli, G.; Jayasinghe, C.; Michel-Schmidt, R.; Kirkpatrick, C.J. Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer. Int. J. Mol. Med. 2007, 20, 21-29.
18. Eyking, A.; Ey, B.; Rünzi, M.; Roig, A.I.; Reis, H.; Schmid, K.W.; Gerken, G.; Podolsky, D.K.; Cario, E. Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer. Gastroenterology 2011, 141, 2154-2165.
19. Galizia, G.; Orditura, M.; Romano, C.; Lieto, E.; Castellano, P.; Pelosio, L.; Imperatore, V.; Catalano, G.; Pignatelli, C.; de Vita, F. Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery. Clin. Immunol. 2002, 102, 169-178.
20. Waugh, D.J.; Wilson, C. The interleukin-8 pathway in cancer. Clin. Cancer Res. 2008, 14, 6735-6741.
21. Kawai, T.; Sato, S.; Ishii, K.J.; Coban, C.; Hemmi, H.; Yamamoto, M.; Terai, K.; Matsuda, M.; Inoue, J.; Uematsu, S., et al. Interferon-α induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nature Immunol. 2004, 5, 1061-1068.
22. Uronis, J.M.; Jobin, C. Microbes and colorectal cancer: Is there a relationship? Curr. Oncol. 2009, 16, 22-24.
23. Doan, H.Q.; Bowen, K.A.; Jackson, L.A.; Evers, B.M. Toll-like receptor 4 activation increases Akt phosphorylation in colon cancer cells. Anticancer Res. 2009, 29, 2473-2478.
24. Kigerl, K.A.; Lai, W.; Rivest, S.; Hart, R.P.; Satoskar, A.R.; Popovich, P.G. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J. Neurochem. 2007, 102, 37-50.
25. Garay, R.P.; Viens, P.; Bauer, J.; Normier, G.; Bardou, M.; Jeannin, J.F.; Chiavaroli, C. Cancer relapse under chemotherapy: Why TLR2/4 receptor agonists can help. Eur. J. Pharmacol. 2007, 563, 1-17.
26. Sussman, D.A.; Santaolalla, R.; Bejarano, P.A.; Garcia-Buitrago, M.T.; Perez, M.T.; Abreu, M.T.; Clarke, J. In silico and Ex vivo approaches identify a role for toll-like receptor 4 in colorectal cancer. J. Exp. Clin. Cancer Res. 2014, 33, 45-57.
27. Wang, E.L.; Qian, Z.R.; Nakasono, M.; Tanahashi, T.; Yoshimoto, K.; Bando, Y.; Kudo, E.; Shimada, M.; Sano, T. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br. J. Cancer 2010, 102, 908-915.
28. Spitzer, J.H.; Visintin, A.; Mazzoni, A.; Kennedy, M.N.; Segal, D.M. Toll-like receptor 1 inhibits Toll-like receptor 4 signaling in endothelial cells. Eur. J. Immunol. 2002, 32, 1182-1187.
29. Uehori, J.; Matsumoto, M.; Tsuji, S.; Akazawa, T.; Takeuchi, O.; Akira, S.; Kawata, T.; Azuma, I.; Toyoshima, K.; Seya, T. Simultaneous blocking of human Toll-like receptor 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Gue’rin (BCG)-peptidoglycan (PGN). Infect. Immun. 2003, 71, 4238-4249.
30. Yamamoto, M.; Uematsu, S.; Okamoto, T.; Matsuura, Y.; Sato, S.; Kumar, H.; Satoh, T.; Saitoh, T.; Takeda, K.; Ishii, K.J., et al. Enhanced TLR-mediated NF-IL6 dependent gene expression by Trib1 deficiency. J. Exp. Med. 2007, 204, 2233-2239.
31. Schneider, M.R.; Hoeflich, A.; Fischer, J.R.; Wolf, E.; Sordat, B.; Lahm, H. Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett. 2000, 151, 31-38.
32. Du, J.; Wu, Z.; Ren, S.; Wei, Y.; Gao, M.; Randolph, G.J.; Qu, C. TLR8 agonists stimulate newly recruited monocyte-derived cells into potent APCs that enhance HBsAg immunogenicity. Vaccine 2010, 28, 6273-6281.
33. Beck, B.; Dörfel, D.; Lichtenegger, F.S.; Geiger, C.; Lindner, L.; Merk, M.; Schendel, D.J.; Subklewe, M. Effects of TLR agonists on maturation and function of 3-day dendritic cells from AML patients in complete remission. J. Transl. Med. 2011, 9, 151-165.
34. Zhang, Y.; Yang, H.; Barnie, P.A.; Yang, P.; Su, Z.; Chen, J.; Jiao, Z.; Lu, L.; Wang, S.; Xu, H. The expression of Toll-like receptor 8 and its relationship with VEGF and Bcl-2 in cervical cancer. Int. J. Med. Sci. 2014, 11, 608-613.
35. Grimm, M.; Kim, M.; Rosenwald, A.; Heemann, U.; Germer, C.T.; Waaga-Gasser, A.M.; Gasser, M. Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression. Eur. J. Cancer 2010, 46, 2849-2857.
36. Wang, D.; Precopio, M.; Lan, T.; Yu, D.; Tang, J.X.; Kandimalla, E.R.; Agrawal, S. Antitumor activity and immune response induction of a dual agonist of Toll-like receptors 7 and 8. Mol. Cancer Ther. 2010, 9, 1788-1797.
37. Peris, K.; Micantonio, T.; Fargnoli, M.C.; Lozzi, G.P.; Chimenti, S. Imiquimod 5% cream in the treatment of Bowen’s disease and invasive squamous cell carcinoma. J. Am. Acad. Dermatol. 2006, 55, 324-327.
38. Ning, Y.; Manegold, P.C.; Hong, Y.K.; Zhang, W.; Pohl, A.; Lurje, G.; Winder, T.; Yang, D.; LaBonte, M.J.; Wilson, P.M., et al. Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models. Int. J. Cancer 2010, 1, 2038-2049.
39. Huang, W.S.; Chin, C.C.; Chen, C.N.; Kuo, Y.H.; Chen, T.C.; Yu, H.R.; Tung, S.Y.; Shen, C.H.; Hsieh, Y.Y.; Guo, S.E., et al. Stromal cell-derived factor-1/CXC receptor 4 and β1 integrin interaction regulates urokinase-type plasminogen activator expression in human colorectal cancer cells. J. Cell. Physiol. 2012, 227, 1114-1122.
40. Chiu, Y.W.; Lin, T.H.; Huang, W.S.; Teng, C.Y.; Liou, Y.S.; Kuo, W.H.; Lin, W.L.; Huang, H.I.; Tung, J.N.; Huang, C.Y., et al. Baicalein inhibits the migration and invasive properties of human hepatoma cells. Toxicol. Appl. Pharmacol. 2011, 255, 316-326.